Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAST-AS: AZD7325 in Autism Spectrum Disorder
NCT01966679Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Oct 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azd7325 in Autism Spectrum Disorder (ASD), sponsored by University of California, Los Angeles. Started Oct 2013; status: completed.
02
Drugs
azd7325
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01966679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01966679.